Company Filing History:
Years Active: 2022
Title: Jianghai Liu - Innovator in HER3 Binding Agents
Introduction
Jianghai Liu is a prominent inventor based in Saskatoon, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of HER3 binding agents. His work focuses on creating antibodies and binding fragments that specifically target HER3, a protein associated with various cancers.
Latest Patents
Jianghai Liu holds a patent for "HER3 binding agents and uses thereof." This patent discloses antibodies and binding fragments that specifically bind to HER3. Additionally, it covers immunoconjugates that incorporate these antibodies and binding fragments. The applications of this patent include detecting HER3-expressing cells and treating HER3-expressing cancers. Liu's innovative approach has the potential to enhance cancer diagnostics and therapies.
Career Highlights
Jianghai Liu is affiliated with the University of Saskatchewan, where he conducts his research. His work has garnered attention for its potential impact on cancer treatment. Liu's dedication to advancing medical science is evident in his focused research on HER3 and its implications for cancer therapy.
Collaborations
Some of Jianghai Liu's notable coworkers include Bharathikumar Vellalore Maruthachalam and Ayman Elsayed Mohammad. Their collaborative efforts contribute to the ongoing research and development in the field of HER3 binding agents.
Conclusion
Jianghai Liu's innovative work in HER3 binding agents represents a significant advancement in cancer research. His contributions have the potential to improve diagnostic and therapeutic strategies for HER3-expressing cancers.